BackBGI Genomics , Ltd. Overview

BGI Genomics , Ltd. Current Assets

Track BGI Genomics , Ltd.'s current assets ($5.7B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$5.66B
↓ 13.40% YoYΔ $-875.07M vs prior year quarter

Peer trimmed avg / median

Loading

BGI Genomics , Ltd. Current Assets History

Loading

BGI Genomics , Ltd. vs. peers: Current Assets Comparison

Loading

BGI Genomics , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BGI Genomics , Ltd. (300676.SZ) FAQ

BGI Genomics , Ltd. posts a current assets of $5.7B as of September 2026. That compares with $6.5B in the prior-year period — down 13.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BGI Genomics , Ltd.'s current assets was $6.5B. The latest reading is $5.7B — a 13.4% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of BGI Genomics , Ltd.'s financial statement story. At $5.7B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 300676.SZ's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BGI Genomics , Ltd.'s other metric pages and overview cover the third.